AI
AdvisorShares Investments Portfolio holdings
AUM
$555M
1-Year Return
19.49%
This Quarter Return
-6.16%
1 Year Return
+19.49%
3 Year Return
+67.68%
5 Year Return
+78.74%
10 Year Return
–
AUM
$370M
AUM Growth
+$11.1M
(+3.1%)
Cap. Flow
+$43.6M
Cap. Flow
% of AUM
11.76%
Top 10 Holdings %
Top 10 Hldgs %
60.9%
Holding
358
New
127
Increased
63
Reduced
76
Closed
45
Top Buys
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$38.9M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
$3.42M |
| 3 |
Occidental Petroleum
OXY
|
$1.42M |
| 4 |
Ovintiv
OVV
|
$1.29M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$1.22M |
Top Sells
| 1 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
$41.2M |
| 2 |
Innovative Industrial Properties
IIPR
|
$2.48M |
| 3 |
RYM
RYTHM, Inc. Common Stock
RYM
|
$1.92M |
| 4 |
GrowGeneration
GRWG
|
$1.4M |
| 5 |
Eli Lilly
LLY
|
$889K |
Sector Composition
| 1 | Real Estate | 9.82% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Healthcare | 6.62% |
| 4 | Industrials | 6.51% |
| 5 | Energy | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
176
DELISTED
Paramount Global Class B
PARA
| $388K | 0.1% |
+20,370
| New | +$388K |
|
177
Tapestry
TPR
$21.7B
| $388K | 0.1% |
+13,648
| New | +$388K |
|
178
Churchill Downs
CHDN
$7.18B
| $387K | 0.1% |
+4,200
| New | +$387K |
|
179
Relmada Therapeutics
RLMD
$54.8M
| $387K | 0.1% |
+10,458
| New | +$387K |
|
180
Group 1 Automotive
GPI
$6.26B
| $386K | 0.1% |
+2,700
| New | +$386K |
|
181
PennyMac Financial
PFSI
$6.08B
| $384K | 0.1% |
+8,962
| New | +$384K |
|
|
PMT
182
PennyMac Mortgage Investment
PMT
$1.1B
| $384K | 0.1% |
+32,592
| New | +$384K |
|
|
QNTM
183
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM
$53.6M
| $380K | 0.1% |
6,962
+2,242
| +48% | +$122K |
|
|
ROCC
184
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $378K | 0.1% |
+12,018
| New | +$378K |
|
185
Celanese
CE
$5.34B
| $377K | 0.1% |
+4,176
| New | +$377K |
|
186
Olin
OLN
$2.9B
| $376K | 0.1% |
+8,760
| New | +$376K |
|
|
ITCI
187
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $376K | 0.1% |
+8,076
| New | +$376K |
|
188
Sylvamo
SLVM
$1.83B
| $373K | 0.1% |
+11,000
| New | +$373K |
|
189
Williams-Sonoma
WSM
$24.7B
| $372K | 0.1% |
+6,316
| New | +$372K |
|
190
Nucor
NUE
$33.8B
| $370K | 0.1% |
+3,462
| New | +$370K |
|
191
Sinclair Inc
SBGI
$964M
| $368K | 0.1% |
+20,370
| New | +$368K |
|
192
Newmark Group
NMRK
$3.28B
| $365K | 0.1% |
+45,324
| New | +$365K |
|
|
SAGE
193
DELISTED
Sage Therapeutics
SAGE
| $362K | 0.1% |
+9,232
| New | +$362K |
|
194
Century Casinos
CNTY
$83.2M
| $353K | 0.1% |
53,761
+40,495
| +305% | +$266K |
|
|
DRUG
195
Bright Minds Biosciences
DRUG
$299M
| $351K | 0.09% |
57,056
-859
| -1% | -$5.28K |
|
196
GrafTech
EAF
$256M
| $351K | 0.09% |
+8,148
| New | +$351K |
|
|
X
197
DELISTED
US Steel
X
| $351K | 0.09% |
+19,352
| New | +$351K |
|
198
GH Research
GHRS
$874M
| $349K | 0.09% |
30,056
+5,221
| +21% | +$60.6K |
|
199
British American Tobacco
BTI
$122B
| $341K | 0.09% |
9,617
+6,500
| +209% | +$230K |
|
200
Enveric Biosciences
ENVB
$2.95M
| $331K | 0.09% |
5,224
+3,554
| +213% | +$225K |
|